ArticlePloS one2025
Characterization and prediction of non-melanoma skin cancer incidence in China: Joinpoint regression and age-period-cohort model.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Shifting Landscape of HIV-Tuberculosis Co-Infection in the MENA Region with a Focus on Saudi Arabia: A Systematic Epidemiological Analysis over Three Decades.Infectious diseases and therapy · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveUnderstanding the non-melanoma skin cancer (NMSC) incidence and its trends in China is an important prerequisite for effective prevention and control of NMSC.
methodsNMSC incidence data was collected from the Annual Report of China Cancer Registry from 2005 to 2018. The Joinpoint regression model was used to estimate the average annual percent change (AAPC) and annual percent change (APC) to reflect the time trend. Age-period-cohort model with the intrinsic estimator algorithm was used to analyze age, period, and cohort effects. Bayesian age-period-cohort (BAPC) model with integrated nested laplace approximation was used for prediction.
resultsThe age-standardized incidence rate (ASIR) of NMSC increased from 1.02/ 100,000 to 1.63/100,000 from 2005 to 2018, showing an increasing trend with AAPC of 3.7% (95% CI: 2.5%, 4.9%). The ASIR was higher in men than in women, while the increase rate was reversed, and it was lower in rural than in urban areas, while AAPC was 1.15 times higher. The risk of NMSC incidence increased with age. The cohort effect was first to increase and then to decrease and the inflection point appeared in 1930-1934. The ASIR of NMSC in China will continue to rise during 2019-2035.
conclusionThe ASIR of NMSC in China from 2005 to 2018 showed an increasing trend with age, gender, and regional differences, and will continue to increase in the future. NMSC remains a public health problem and requires continuous attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.